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Background: Lymphedema is a highly prevalent condition in women who have undergone treatment for breast
cancer. Lymphedema negatively affects the quality of life. The objective of this study was to estimate the prevalence of
lymphedema and associated factors in women treated for breast cancer in the municipality of Juiz de Fora.
Methods: We performed a cross-sectional study that evaluated 250 women who were being treated for breast cancer.
Pre-screening of the sample by analysis of medical records was performed to select women who met the inclusion
criteria as follows: women who had an operation more than 6 months ago; absence of active disease, locoregional or
distant; the absence of functional change in the affected limb before surgery, which could lead to swelling of the limb;
and simulating or masking symptoms of lymphedema, such as bursitis, tendonitis, and work-related musculoskeletal
disorders. Women with bilateral breast cancer, absence of axillary intervention (partial or complete axillary dissection
and/or SLN biopsy), active disease in the region, or lympho-venous alteration of the limb before surgery were excluded.
Data were collected from the medical records of the selected cases, and they subsequently underwent an interview and
a physical assessment.
Results: The prevalence of lymphedema was 44.8%. There were medical records on the presence of this condition in
5.4% of cases. With regard to shoulder joint mobility, restrictions on abduction movements, internal and external
rotation, and anterior shoulder adduction were significantly associated with lymphedema. Variables, including the
presence of seroma, vascular changes, time elapsed after surgery, episodes of redness in the extremities, and cuticle
removal from the hand with pliers were considered as major associated factors for lymphedema (p<0.05).
Conclusions: The prevalence of 44.8% for lymphedema found in this study is considered to be relevant because it is a
morbidity that produces psychological, physical, and functional damage in patients with this condition. The planning of
health programs and services appropriate for the immediate postoperative treatment of women with breast cancer, and
increasing the awareness of health professionals regarding the early diagnosis of lymphedema, can help minimize the
morbidity of this disease.
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Breast cancer is considered the second leading cause of
mortality and morbidity among women in Brazil [1]. The
approaches used to control and treat breast cancer have
been well studied to the extent that they have led to
increased survival of these women [2]. Therefore, there is
growing interest in seeking resources and alternatives
that could improve the quality of life of breast cancer
patients [3-6]. There is also a need to understand the be-
havior of morbidities from breast cancer that may occur
because of tumor development and the therapies used.
There is still a high number of late diagnoses that con-
tribute to the election of more aggressive therapy and
subsequent traumatic surgery [2,7,8]. This necessitates
the improvement of therapeutic techniques to reduce the
number of comorbidities presented. Among the notable
major innovations are breast surgery techniques and axil-
lary approaches, such as sentinel lymph node (SLN) bi-
opsy [7-10]. Even with the use of these approaches,
studies show a high prevalence of postoperative mor-
bidities, mainly regarding lymphedema [7,11-13]. This
condition arises from disruption of the lymphatic sys-
tem in coping with the axillary approach for staging or
control of the disease [8,14]. Recent studies on the
prevalence of lymphedema and associated factors in
specific populations show varying results [8,9,15,16]
possibly owing to differing diagnostic methods for de-
tection of lymphedema and to sampling differences. Im-
proving the knowledge regarding risk factors specifically
associated with lymphedema in a given population will
aid in the formulation of protocols for both its preven-
tion and its treatment, enabling an improved quality of
life for these women.
In the municipality of Juiz de Fora, Minas Gerais,
southeastern Brazil, there are cancer treatment centers
extending services to neighboring micro and macro
regions, thus offering a potent sampling source for re-
search in the area.
This study aimed to ascertain the prevalence of lym-
phedema in women undergoing treatment for breast can-
cer in a referral unit for cancer treatment in the
municipality of Juiz de Fora, as well as associated risk
factors. We hypothesized that the prevalence of lymphe-
dema is high and is associated with the time elapsed
since surgery and comorbidities among these women.
Methods
During the period from August 2009 to June 2010, a total
of 250 women, who came to the clinic for an oncology
(chemotherapy and/or radiotherapy) follow-up visit, were
evaluated at a specialized hospital in the municipality of
Juiz de Fora. Pre-screening of the sample by analysis of
medical records was performed to select women who
met the inclusion criteria as follows: women who had anoperation more than 6 months ago; absence of active dis-
ease, locoregional or distant; the absence of functional
change in the affected limb before surgery, which could
lead to swelling of the limb; and simulating or masking
symptoms of lymphedema, such as bursitis, tendonitis,
and work-related musculoskeletal disorders.
All eligible women were invited to participate in the
study, and upon signing the consent form, only four
women refused to participate. Women with bilateral
breast cancer, absence of axillary intervention (partial or
complete axillary dissection and/or SLN biopsy), active
disease in the region, or lympho-venous alteration of the
limb before surgery were excluded.
Data were collected from the medical records of the
selected cases, and they subsequently underwent an
interview and a physical assessment. Records were
analyzed to obtain data regarding the treatment of
breast cancer, axillary intervention, seromas, vascular
implications, and tumor staging. A semi-structured
questionnaire was used for subjective diagnosis of
lymphedema and its possible associated factors, fol-
lowed by the administration of a physical examination
for clinical diagnosis and detection of co-existing
morbidities. The elapsed time from surgery until the
date of the interview was divided into two categories:
beyond or within 5 years. Current pain was estimated
using the Visual Analog Scale categorized into 10
recording intervals for de-registration.
The physical examination was performed by only one
evaluator, who was qualified and trained for this type of
approach. The criterion for the diagnosis of lymphedema
was obtained by perimetry with the use of a measuring
tape, with measurements obtained after adjustment of
the dominant arm and time since diagnosis [7,14]. Mea-
surements were taken at seven points: at the inside of
the elbow in the supine position (taken as the zero
point), and three measurements above and below this
point, at intervals of 7.0 cm. Lymphedema was charac-
terized as when the difference between the affected limb
and the contralateral (control) limb, using at least one
measurement, was equal to or greater than 2.0 cm
[7,12,14,17]. This study met the requirements of the
Declaration of Helsinki and was approved by the Institu-
tional Ethics Committee of the Federal University of Juiz
de Fora (reference number: 050/2009).
Statistical analysis
The data were processed in a database created with the
Statistical Package for Social Sciences version 14.0
(SPSS Inc., Chicago, IL) and Stata 10.0 (StataCorp,
Texas). The significance level of the study was 95%
(p≤0.05). The presence or absence of lymphedema was
considered the dependent variable. The independent vari-
ables were aggregated and analyzed in blocks, combined
Table 1 Symptoms and presence of AWS in the arm
ispilateral to the surgery, Brazil, 2010
Variables % P
Presence of seroma No 25.0 <0.001
Yes 75.0
Heat Sensation in the scar No 73.2 0.05
Yes 26.8
Pain in the scar No 48.2 0.013
Yes 51.8
Heat sensation in the upper limb No 63.4 0.015
Yes 36.6
Pain in any part of the upper limb No 27.7 <0.001
Yes 72.3
Burning sensation in any part of the upper limb No 69.6 0.012
Yes 30.4
Episode of redness in any part of the upper limb No 66.1 <0.01
Yes 33.9




Variables related to variables for women, such as symptoms and presence of
AWS in the arm ispilateral to the surgery in the postoperative period,
associated with lymphedema following surgical treatment for breast cancer,
Juiz de Fora (MG), Brazil, 2010.
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ables, characteristics concerning the diagnosis and treat-
ment of cancer, symptoms and presence of Axillary Web
Syndrome (AWS) or superficial lymphatic thrombosis in
the upper limb ipsilateral to surgery in the postoperative
period, information regarding the care and early movement
of the limb ipsilateral to surgery, and variables associated
with lymphedema in women after surgical treatment of
breast cancer. These factors were adjusted for variables
on self-reported morbidities, treatment characteristics,
and postoperative characteristics. Descriptive analysis was
used to obtain absolute and relative frequencies of the
analysis variables, as well as for the prevalence of the out-
come investigated. Bivariate analysis was performed to as-
sess the association of each independent variable with the
dependent variable, using the chi-square (χ2) test. In
multivariate analysis, Poisson regression was used to
analyze the independent variables associated with out-
come, controlling for potential confounders, such as the
dominant arm and time since diagnosis (adjusted preva-
lence ratio). The Poisson regression in each block of ana-
lysis combined variables with a crude p-value <0.20, and
between the blocks, the adopted significance was 5%. The
significance level was tested using the Wald test for het-
erogeneity and linear trend.
Results
The prevalence of lymphedema in the upper limb ipsilat-
eral to breast surgery was 44.8% (112/250 women).
There were medical records on the presence of this con-
dition in 5.4% of cases (6/250 cases). The time elapsed
after surgery was significantly associated with the preva-
lence of lymphedema (p=0.028).
With regard to variables from the postoperative period,
the presence of seroma and symptoms, such as redness,
were significantly associated with lymphedema (p<0.001)
after adjustment by the regression model (Table 1).
Physical examination showed that 49.6% (124/250) of
the women with lymphedema had superficial lymphatic
thrombosis, which demonstrated an association with
lymphedema in bivariate analysis (p<0.001).
The mean age of patients with lymphedema was
56±11,58 and there was no significant difference in
age compared with those without lymphedema (p=0.24).
The two groups were similar with respect to variables, such
as schooling (p=0.39), obesity (p=0.35), and skin color
(p=0.15). In the presence of comorbidities, women
with vascular implications (thrombosis, varicose veins,
circulatory changes in the lower and/or upper limbs,
and others) had a frequency of 2.7 times greater for
developing lymphedema (p=0.02). There was no dif-
ference between the groups for other self-reported
health conditions, including hypertension (p=0.30)
and diabetes mellitus (p=0.49, Table 2).Women who had undergone surgery more than 5 years
previously had a 9.7 times higher frequency of lymphe-
dema compared with those who had undergone surgery
less than 5 years previously (p=0.02). The analysis of
other variables related to cancer treatment is shown in
Table 3.
With regard to shoulder joint mobility, restrictions on
abduction movements, internal and external rotation,
and anterior shoulder adduction were significantly asso-
ciated with lymphedema (p<0.001).
There was no significant association with outcome for
almost all of the variables related to information that the
patients received from the healthcare team on caring for
their limbs and guidance on early movement after sur-
gery, except for the variable of cuticle removal from the
hand with pliers. This variable remained associated with
lymphedema even when adjusted for other variables,
such as self-reported morbidities and characteristics of
the implemented treatment (p=0.02, Table 4).
All variables that proved to be significant after adjust-
ment within the block to which they belonged were sub-
jected to Poisson regression to build the final model.
Variables that remained significant were vascular disor-
ders (p=0.08), the presence of redness in any region of
the arm after surgery (p<0.001), the presence of seroma
(p<0.001), and cuticle removal with pliers from the hand
corresponding to the limb ipsilateral to surgery (p=0.013),
Table 2 Women’s socio-demographic and self-reported health characteristics, Brazil, 2010
Variable Variable category % Crude PR (CI 95%) p Adjusted PR a (CI 95%) p
Age up to 56 years 49.1 1 0.17 1 0.20
57–75 years 50.9 1.30(0.79–2.15) 1.40(0.79–2.45)
Skin color non-White 59.8 1 0.05 1 0.15
White 40.2 1.58(0.94–2.68) 1.51(0.85–2.66)
Schooling Secondary/higher 37.5 1 0.13 1 0.39
Primary 52.7 1.18(0.70–2.00) 1.78(0.55–5.72)
Illiterate 9.8 2.24(0.80–6.26) 1.61(0.54–4.79)
Obesity No 70.5 1 0.19 1 0.35
Yes 29.5 1.31(0.77–2.25) 1.31(0.74–2.32)
Vascular changes No 95.5 1 0.00 1 0.02
Yes 4.5 3.84(1.39–10.54) 3.67(1.22–1.11)
aVariables adjusted within their blocks.
Women’s socio-demographic and self-reported health characteristics, associated with the occurence of lymphedema following surgical treatment for breast
cancer, Juiz de Fora (MG), \Brazil, 2010.
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model (Table 5).
Discussion
The current study found that the prevalence of patients
with lymphedema after treatment for breast cancer was
44.8%. However, it is possible that underestimation oc-
curred because the average time spent in the postopera-
tive period in our sample was 5 years, and the higher a




Type of surgery (breast) Conservative
Radical











Area administered radiotherapy Biopsy
Axilla-breast
Breast, axilla, supraclavicular fossa
aVariables adjusted within their blocks.
Characteristics regarding the diagnosis and treatment of cancer in women, associat
cancer, Juiz de Fora (MG), Brazil, 2010.chances of developing lymphedema. The possibility of
survival bias cannot be ruled out because more severe
cases subjected to more drastic measures may not have
maintained contact owing to death, and therefore were
not included in this sample. The prevalence of lymphe-
dema found in this study is higher than the prevalence
rates between 9% and 40% reported by other studies
[8,9,12,15,16,18,19]. This difference between prevalence
rates could be attributed to the type of method used to
diagnose lymphedema, because there are several methodst of cancer in women, Brazil, 2010
% Crude PR(CI 95%) p Adjusted PR a (CI 95%) p
46.4 1 0.001 1 0.216
43.8 2.23(1.33–3.72) 1.15(0.78–2.92)
40.2 1 0.04 1 0.91
59.8 0.63(0.38–1.04) 0.96(0.45–2.00)
6.3 1 <0.01 1 0.52
42.0 3.76(1.50–9.42) 1.81(0.53–6.17)
35.7 4.44(1.73–11.40) 1.42(0.39–5.18)
11.6 1 <0.01 1 0.69
87.5 3.22(1.62–6.38) 4.71(0.62–5.74)




56.3 1 0.008 1 0.13
28.6 2.67(1.27–5.59) 2.83(0.93–8.56)
15.2 2.66(1.17–6.02) 1.52(0.47–4.86)
ed with the occurence of lymphedema following surgical treatment for breast
Table 4 Care and early movement of the limb ipsilateral to surgery in women, Brazil, 2010
Variables % Crude PR (CI 95%) p Adjusted PRa (CI 95%) p
Removing hand cuticles with pliers Yes 40.2 1 0.06 1 0.02
No 59.8 1.53 (0.92–25) 2.10(1.11–3.95)
Armpit depilation by razor blade or waxing Yes 34.8 1 0.10 1 0.81
No 65.2 1.43 (0.86–2.41) 1.13(0.39–3.31)
Carry weight with the affected limb Yes 60.7 1 0.09 1 0.54
No 39.3 1.47(0.84–20.40) 1.307(0.54–3.11)
Receive vaccines and/or injections in the limb Yes 54.5 1 0.08 1 0.96
No 45.5 1.47(0.88–20.40 1.02(0.39–2.63)
Injury/burn in any part of the limb Yes 36.6 1 0.04 1 0.32
No 63.4 1.58(0.95–2.63) 1.84(0.54–6.28)
Guidance on exercising in the postoperative period First day until first month 22.3 1 0.05 1 0.12
After losing movement 23.2 0.67(0.34–1.31) 1.25(0.61–2.54)
Didn’t receive guidance 54.5 (1.67(0.92–3.02) 1.94(0.91–4.18)
aVariables adjusted within their blocks.
Variables related to the clarification received regarding the care and early movement of the limb ipsilateral to surgery in women, associated with lymphedema
following surgical treatment for breast cancer Juiz de Fora (MG), Brazil, 2010.
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the fact that the institution in which the data were col-
lected does not offer a service specializing in prevention
and treatment of lymphedema. Perimetry, which was the
diagnostic method used in this study, is based on com-
paring the measurement of the circumference of the
affected arm with the contralateral arm [7,9,14,17]. Fur-
thermore, in Brazil, delayed diagnosis is common, caus-
ing more aggressive surgeries, which could be an
important reason for the high prevalence of lymphedema
in this study.
Age is a variable often associated with lymphedema
[7,19-22]. Along with the aging process, anatomical and
physiological changes related to lymphatic obstruction
occur, which may predispose to the development of lym-
phedema, with the main mechanism being the opening
of lympho-venous anastomoses [7,22-24]. The higher in-
cidence of lymphedema in older patients observed inTable 5 Variables associated with lymphedema in women aft
Variables % Crude PR (C
Vascular pathologies No 95.5 1
Yes 4.5 3.67(1.22–
Seroma No 25.0 1
Yes 75.0 3.01(1.61–
Arm redness No 66.1 1
Yes 33.9 8.11(2.20–
Cuticle removal No 33.9 1
Yes 66.1 2.10(1.116
a Adjusted between blocks.
Variables associated with lymphedema in women after surgical treatment of breast
characteristics, and postoperative characteristics. Juiz de Fora (MG), Brazil, 2010.some studies [7,19,23,25] may be due to a progressive
loss of these anastomoses because of the aging process
[12,24]. This finding was not observed in the current
study, where the average age of the patients with lym-
phedema was 56 years, with no significant difference be-
tween those with and those without lymphedema.
Likewise, a study by Yen et al., [20] who investigated
self-reporting of the risk factors for lymphedema in
older women, also found no significant difference be-
tween women with and those without lymphedema. The
difference in evaluation methods and the average age of
the women involved in these studies may be responsible
for the discrepancy of results.
In attempting to reestablish the lympho-venous bal-
ance of the upper limb and breast region after breast
cancer treatment, the body makes use of compensatory
mechanisms, which attempt to avoid edema. However,
some factors such as trauma, aging, and repetitive orer surgical treatment of breast cancer, Brazil, 2010









cancer, after adjustments for variables on self-reported morbidities, treatment
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lymphatic system, changing the balance. Therefore, the
longer the time elapsed since surgery, the greater the
risk of developing lymphedema, because this increases
the chances of a woman being exposed to injury [17].
Radiotherapy is considered as a risk factor for develop-
ment of lymphedema, mainly when axillary irradiation is
applied [7,13,26]. A likely explanation is the occurrence
of lymphedema due to the blockage of lymph vessels or
their compression by fibrosis caused by this treatment
[25,27,28]. According to Bergmann et al., [7] the main
risk factor associated with lymphedema after treatment
for breast cancer is the axillary approach, both surgical
and radiotherapy, followed by age. Our study differs
from previous studies in that there was no association
between the irradiation site and the development of
morbidity when controlled by other variables.
AWS, otherwise known as superficial lymphatic throm-
bosis, is the formation of a palpable network of cords that
can extend from the armpit, through the antecubital space
to the base of the thumb. AWS is caused by possible for-
mation and displacement of fibrin clots in the superficial
veins and lymphatic capillaries, which form a network
[8,20,29]. In the current study, the presence of AWS in bi-
variate analysis was statistically significant (p<0.001). How-
ever, when AWS was analyzed in the adjusted model, it
lost its significance. This syndrome is accompanied by
acute pain symptoms that may regress spontaneously
(~3 months after surgery) or become chronic, when the
formation of a fibrotic cord occurs, and this restricts the
range of motion of the shoulder [30,31]. The presence of
AWS contributes to the formation or worsening of lym-
phedema [26,29,31].
Some studies question the validity of current guideline
“manuals” for the prevention of lymphedema, because they
believe that despite the biological plausibility, no evidence
has been shown for the validity of these treatments
[6,7,32]. Therefore, it is prudent for the patient to take cer-
tain care of the arm, but this should not affect or impair
the patient’s daily routine. The occurrence of minor injur-
ies, such as cuts, bruises, minor burns, and infection, trig-
gers an inflammatory response. This translates into an
increase of fluid filtered by the arterial capillaries into the
interstitium, capillaries and lymphatic vessels, which over-
loads the lymphatic system already damaged by lymphade-
nectomy [10,12,20,24]. This process may intensify,
generating local symptoms, as well as general symptoms,
giving rise to the appearance of erysipelas and/or lymphan-
gitides [20,25,27]. The removal of cuticles during nail care
allows easy access to bacteria, by producing a skin lesion,
facilitating an inflammatory process that can precede or
aggravate lymphedema [4,19,26].
The prevalence of moderate to severe symptoms in
women who avoid movement of the ipsilateral arm aftersurgery is significantly higher than in those who do not
avoid it. These data are corroborated by several studies
[6,9,16,20] in which changes in movements of the shoulder
after surgery for breast cancer were investigated, at various
times after surgery, to determine the effect of early exercise
intervention through physiotherapy [18,32,33]. In the
present study, only 119 women (47.6%) received some type
of information concerning various treatments for the limb
and the importance of early motion. In this case, besides
harm from the lack of intervention supervised by a profes-
sional, the guidance of self care alone leads to misinterpret-
ation, resulting in failure to perform adequate exercises.
Studies of lymphedema have shown a positive association
between the receipt of information and the avoidance of
movement [7,16,20,34,35]. In our study, an important asso-
ciation was found between lymphedema and the lack of in-
formation regarding movement of the limb, although this
was not statistically significant in multivariate analysis.Conclusions
Lymphedema is a multifactorial morbidity. Therefore, an
interdisciplinary approach is required. The prevalence of
44.8% for lymphedema found in this study is considered
relevant because it is a morbidity that produces psycho-
logical, physical, and functional damage in patients with
this condition. Lymphedema is associated with the time
elapsed after surgery, associated vascular pathologies, the
presence of seroma, episodes of redness in some parts of
the limb after surgery, and cuticle removal with pliers
from the hand ipsilateral to the surgery. The surgical
method, as well as the extent of the axillary approach, the
area administered radiotherapy, and application of chemo-
therapy show a positive, but not significant, association
with the presence of lymphedema.
We conclude that lymphedema is a preventable mor-
bidity. The planning of health programs and services ap-
propriate to the immediate postoperative treatment of
women with breast cancer, and increasing the awareness
of health professionals regarding the early diagnosis of
lymphedema, can help minimize morbidity. Understand-
ing and improved definitions of the associated factors
could be important tools for treatment of this condition.
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